Eligibility Multiple Sclerosis NCT00104143

Inclusion Criteria
Descrição

Inclusion Criteria

Alias
UMLS CUI
C1512693
adult patients, 18-59 years of age;
Descrição

Adult | Age

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0001675
UMLS CUI [2]
C0001779
relapsing multiple sclerosis patients with types 1-4 (established through mcdonald criteria);
Descrição

Relapsing Multiple Sclerosis Type

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0393664
UMLS CUI [1,2]
C0332307
>=1 ms attack or a gd-enhancing mri lesion between 1 month and 1 year before enrollment;
Descrição

Multiple Sclerosis Attack Quantity | Gadolinium-Enhancing Lesion MRI

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0026769
UMLS CUI [1,2]
C1304680
UMLS CUI [1,3]
C1265611
UMLS CUI [2,1]
C1333400
UMLS CUI [2,2]
C0024485
edss score of <=6.5;
Descrição

EDSS

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0451246
inadequate response to approved treatment(canada only).
Descrição

Response to treatment Inadequate

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0521982
UMLS CUI [1,2]
C0205412
Exclusion Criteria
Descrição

Exclusion Criteria

Alias
UMLS CUI
C0680251
ms attack within 1 month before enrollment;
Descrição

Multiple Sclerosis Attack

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0026769
UMLS CUI [1,2]
C1304680
systemic corticosteroids within 1 month before enrollment;
Descrição

Systemic steroids

Tipo de dados

boolean

Alias
UMLS CUI [1]
C2825233
ms treatments (non-symptomatic) within specified periods before enrollment;
Descrição

Treatments Multiple Sclerosis Asymptomatic

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0026769
UMLS CUI [1,3]
C0231221
an infection requiring systemic anti-infective treatment or vaccination with a live vaccine within 1 month before enrollment.
Descrição

Communicable Disease Requirement Anti-infective therapy Systemic | Communicable Disease Requirement Vaccination Live vaccine

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0009450
UMLS CUI [1,2]
C1514873
UMLS CUI [1,3]
C1141958
UMLS CUI [1,4]
C0205373
UMLS CUI [2,1]
C0009450
UMLS CUI [2,2]
C1514873
UMLS CUI [2,3]
C0042196
UMLS CUI [2,4]
C0042211

Similar models

Eligibility Multiple Sclerosis NCT00104143

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
C1512693 (UMLS CUI)
Adult | Age
Item
adult patients, 18-59 years of age;
boolean
C0001675 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
Relapsing Multiple Sclerosis Type
Item
relapsing multiple sclerosis patients with types 1-4 (established through mcdonald criteria);
boolean
C0393664 (UMLS CUI [1,1])
C0332307 (UMLS CUI [1,2])
Multiple Sclerosis Attack Quantity | Gadolinium-Enhancing Lesion MRI
Item
>=1 ms attack or a gd-enhancing mri lesion between 1 month and 1 year before enrollment;
boolean
C0026769 (UMLS CUI [1,1])
C1304680 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
C1333400 (UMLS CUI [2,1])
C0024485 (UMLS CUI [2,2])
EDSS
Item
edss score of <=6.5;
boolean
C0451246 (UMLS CUI [1])
Response to treatment Inadequate
Item
inadequate response to approved treatment(canada only).
boolean
C0521982 (UMLS CUI [1,1])
C0205412 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
Multiple Sclerosis Attack
Item
ms attack within 1 month before enrollment;
boolean
C0026769 (UMLS CUI [1,1])
C1304680 (UMLS CUI [1,2])
Systemic steroids
Item
systemic corticosteroids within 1 month before enrollment;
boolean
C2825233 (UMLS CUI [1])
Treatments Multiple Sclerosis Asymptomatic
Item
ms treatments (non-symptomatic) within specified periods before enrollment;
boolean
C0087111 (UMLS CUI [1,1])
C0026769 (UMLS CUI [1,2])
C0231221 (UMLS CUI [1,3])
Communicable Disease Requirement Anti-infective therapy Systemic | Communicable Disease Requirement Vaccination Live vaccine
Item
an infection requiring systemic anti-infective treatment or vaccination with a live vaccine within 1 month before enrollment.
boolean
C0009450 (UMLS CUI [1,1])
C1514873 (UMLS CUI [1,2])
C1141958 (UMLS CUI [1,3])
C0205373 (UMLS CUI [1,4])
C0009450 (UMLS CUI [2,1])
C1514873 (UMLS CUI [2,2])
C0042196 (UMLS CUI [2,3])
C0042211 (UMLS CUI [2,4])